Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

AIM/FUM stock hub

AIM/FUM has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

AIM/FUMis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

4.1M

London Stock Exchange AIM

Market data

Live price

Current market quote for this ticker.

Current price

AIM/FUM

In the news

Latest news · AIM/FUM

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12.9P50 16.9P75 23.5

Trailing P/En/a

P25 15.9P50 22.9P75 35.8

ROE-116

P25 -54.2P50 2.1P75 13.7

ROIC-72.5

P25 -38.1P50 3.3P75 11.9

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All AIM/FUM market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

183

Groups with data

Currency

GBP

Showing 183 of 183 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	United Kingdom
Country code	UK
Employees	14
Employees Change	2%
Employees Change Percent	16.67
Enterprise value	GBX 379,744
Exchange	London Stock Exchange AIM
Financial currency	GBP
First seen	2026-05-10
Industry	Biotechnology
Isin	GB0033278473
Last refreshed	2026-05-10
Market cap	GBX 4.1M
Price	GBX 0.7
Price currency	GBX
Rev Per Employee	566,184.5x
Sector	Healthcare
Sic	2834
Symbol	aim/FUM
Website	https://www.futuramedical.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-154.69%
EV Earnings	-0.06x
EV/FCF	-0.86x
EV/Sales	0.05x
FCF yield	-10.82%
P/B ratio	1.34x
P/S ratio	0.51x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-79.48%
EBITDA Margin	-77.91%
Gross margin	64.49%
Gross Profit	GBX 5.1M
Gross Profit Growth	-47.24%
Gross Profit Growth Q	-94.96%
Gross Profit Growth3 Y	42.29%
Net Income	GBX -6.3M
Net Income Growth Years	0%
Pretax Margin	-79%
Profit Margin	-79.41%
Profit Per Employee	GBX -449,614
ROA	-52.66
Roa5y	-39.85
ROCE	-185.9
ROE	-116
Roe5y	-163.1
ROIC	-72.54

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	-27.06%
Cagr15y	-26.51%
Cagr1y	-92.04%
Cagr20y	-21.07%
Cagr3y	-76.06%
Cagr5y	-56.8%
EPS Growth Years	0
OCF Growth3 Y	-6.69%
Revenue Growth	-5.62x
Revenue Growth Q	-85.7x
Revenue Growth Years	0x
Revenue Growth3 Y	36.73x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	GBX 1.06
Assets	GBX 5.5M
Cash	GBX 3.7M
Current Assets	GBX 4.7M
Current Liabilities	GBX 2.1M
Equity	GBX 3M
Liabilities	GBX 2.4M
Long Term Assets	GBX 807,605
Long Term Liabilities	GBX 342,588
Net Cash	GBX 3.7M
Net Cash By Market Cap	GBX 90.67
Net Cash Growth	-5.89%
Net Debt Equity	GBX -1.21
Tangible Book Value	GBX 3M
Tangible Book Value Per Share	GBX 0.01
WACC	4.32

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	2.23
Inventory Turnover	166.3
Net Working Capital	GBX -1.1M
Quick ratio	2.11
Working Capital	GBX 2.6M
Working Capital Turnover	GBX 2.22

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-0.7%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	-95.73%
1Y total return	-92.03%
200-day SMA	3.33
3Y total return	-98.63%
50-day SMA	1.15
50-day SMA vs 200-day SMA	50under200
5Y total return	-98.49%
All Time High	111.2
All Time High Change	-99.37%
All Time High Date	2012-04-04
All Time Low	0.6
All Time Low Change	16.67%
All Time Low Date	2026-05-05
ATR	0.2
Beta	0.01
Beta1y	-0.17
Beta2y	0
Ch YTD	-37.22
High	0.78
High52	15
High52 Date	2025-07-11
High52ch	-95.33%
Low	0.64
Low52	0.6
Low52 Date	2026-05-05
Low52ch	16.67%
Ma50ch	-39.13%
Price vs 200-day SMA	-78.95%
RSI	29.54
RSI Monthly	29.79
RSI Weekly	27.71
Sharpe ratio	-1.44x
Sortino ratio	-1.87
Total Return	-0.7%
Tr YTD	-37.22
Tr15y	-99.02%
Tr1m	-33.01%
Tr1w	-6.17%
Tr3m	-45.1%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	GBX -6.3M
Operating margin	-79.48

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	513,555,633%
Shares Insiders	7.98%
Shares Institutions	83.48%
Shares Out	581,327,755
Shares Qo Q	-0.09%
Shares Yo Y	0.7%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	GBX -1.8M
Average Volume	8,847,561.1x
Bv Per Share	0.01
CAPEX	GBX -903,732
Ch10y	-95.76
Ch15y	-99.02
Ch1m	-33.01
Ch1w	-6.17
Ch1y	-92.03
Ch20y	-99.13
Ch3m	-45.1
Ch3y	-98.63
Ch5y	-98.49
Ch6m	-68.61
Change	0%
Change From Open	0
Close	0.7
Days Gap	0
Depreciation Amortization	124,423
Dollar Volume	2,937,909.8
Earnings Date	2026-04-29
EBIT	GBX -6.3M
EBITDA	GBX -6.2M
EPS	GBX -0.02
F Score	2
FCF	GBX -440,491
FCF EV Yield	-116x
FCF Per Share	GBX -0
Financing CF	181,858
Fiscal Year End	December
Founded	2,001
Income Tax	GBX 32,835
Investing CF	-865,542
Is Primary Listing	1
Last Earnings Date	2026-04-29
Last Report Date	2025-06-30
Ma150	1.45
Ma150ch	-51.82%
Ma20	1.09
Ma20ch	-36.01%
Net CF	-230,778
Open	0.7
P OCF Ratio	8.78
Position In Range	43.42
Ppne	807,605
Price Date	2026-05-08
Ptbv Ratio	1.34
Relative Volume	0.48x
Revenue	7,926,583x
SBC By Revenue	17.04x
Share Based Comp	1,350,764
Tax By Revenue	0.41x
Tr20y	-99.12%
Tr6m	-68.61%
Volume	4,197,014
Z Score	-1.31

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does AIM/FUM pay a dividend?

Capital-return profile for this ticker.

Performance

AIM/FUM stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns AIM/FUM?

Insider, institutional, and short-interest positioning.

Institutional ownership

+83.5%

Share of float held by funds and institutions

Insider ownership

+8.0%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+0.7%

Negative means the company is buying back shares.

Technical

AIM/FUM momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

29.5

Below 30: short-term oversold

Price vs 200-day MA

-78.9%

50/200-day relationship not available

Beta (5Y)

0.01

Less volatile than the market

Sharpe ratio

-1.44

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About AIM/FUM

Hub-level FAQ points readers to the deeper analysis pages.

What is the current aim/FUM stock rating?

aim/FUM is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full aim/FUM analysis?

The full report lives at /stocks/aim/FUM/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for aim/FUM?

The latest report frames aim/FUM around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the aim/FUM page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.